Klaus Orlinger - Apr 14, 2023 Form 4 Insider Report for HOOKIPA Pharma Inc. (HOOK)

Role
Chief Scientific Officer
Signature
/s/ Reinhard Kandera, as Attorney-in-Fact
Stock symbol
HOOK
Transactions as of
Apr 14, 2023
Transactions value $
$0
Form type
4
Date filed
4/18/2023, 07:50 PM
Previous filing
Jul 1, 2022
Next filing
Apr 17, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HOOK Stock Option (Right to Buy) Award $0 +194K $0.00 194K Apr 14, 2023 Common Stock 194K $1.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest on February 15, 2024, with the remainder vesting in 12 equal quarterly installments thereafter.